DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Archives

September 22, 2023
Hear from the Experts: New Research, Clinical Trials, Caregiver Resources & More

Hear from the experts, watch the videos from the 2023 Know All Your Treatment Options and Caregiver events.

Read More
September 19, 2023
Urgent Action: Paid Opportunity for People with Mets Disease to the Brain

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

Read More
September 18, 2023
FDA Widens Temodar's Approval to Fight Another Brain Cancer Type

The FDA expanded use of Temodar to include two new indications for the treatment of adults with anaplastic astrocytoma.

Read More
September 16, 2023
Get Ready to Support EBCI on Giving Tuesday

Get ready to celebrate Giving Tuesday on November 28th, 2023 by supporting EBCI's services and programs.

Read More
September 15, 2023
Meet EBCI's Clinical Research Coordinator/Patient Navigator

Shreya Prakash will work with GBM patients to coordinate clinical trials and to provide information on treatments, drugs, and specialists.

Read More
September 7, 2023
rGBM Patients Encouraged to Share Their Experience

Jenn Ortiz, a two-time brain tumor survivor, describes her participation in the Patient Reported Outcomes rGBM study.

Read More
September 6, 2023
Gleolan Tumor Imaging Agent

Gleolan Brain Dye, imaging agent, helps neurosurgeons to see “high grade gliomas” during surgery. Learn about Gleolan.

Read More
September 6, 2023
More Great News For The Fight Against GBM!

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

Read More
September 6, 2023
Elevate the Patient Voice in Mets Disease to the Brain

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

Read More
September 2, 2023
rGBM Study

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
September 2, 2023
PROSPECT PCNSL Study

PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an oral medicine called Tirabrutinib.

Read More
August 24, 2023
Paid Survey for GBM Patients

People living with glioblastoma multiforme (GBM) are invited to participate in this online survey about their experience.

Read More
1 2 3 13

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram